Browsing Tag
efgartigimod
2 posts
Why myasthenia gravis could become the next major test for TG Therapeutics’ BRIUMVI franchise
Find out how TG Therapeutics’ BRIUMVI myasthenia gravis data could expand its autoimmune growth story beyond multiple sclerosis.
How does nipocalimab compare to efgartigimod and rozanolixizumab? FcRn class battlelines in gMG and beyond
Compare nipocalimab, efgartigimod, and rozanolixizumab on efficacy, safety, dosing, pricing, and market strategy in generalized myasthenia gravis treatment.